JUMP REPORT
| Avg Daily Volume: 9,755,647 Market Cap: 44.14B Sector: Technology Short Interest: 1.5 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: .70/share REV: 2,520/M
___________________________________________________________
LAST QTR: EPS: .66/share ACTUAL: .70/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: .75/share REV: 3,640/M
______________________________________________________
FULL YR: EPS: 2.93/share REV: 14,490/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: 52% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 6.48, -5.2, -8.42
POTENTIAL JUMP MOVE: 10%
Links To Latest News and Headlines
In a world where many businesses have shaky balance sheets, some have ignored the crowd and exercised prudence. These cash-heavy companies shine bright for their financial discipline, resilience, and ability to generate solid returns.
The major averages were little changed near noon following the release of downbeat consumer sentiment data and as April housing starts came in slightly below consensus estimates. Investors continue to weigh potentially easing trade tensions as well. Meanwhile, President Trump said in a post on Truth Social that Republican lawmakers “must unite” to pass his “beautiful” tax bill. Looking to commodities, gold prices are slipping after yesterday’s rebound, while oil is up fractionally, keeping the c
The S&P 500 added 0.7% on Friday, May 16, 2025, closing the week with a fifth straight day of gains even as a survey showed sagging consumer sentiment.
UnitedHealth stock is rising after declining for eight consecutive sessions, Applied Materials issues a disappointing revenue outlook, and Doximity falls sharply after its revenue forecast misses analysts’ estimates.
Shares of semiconductor machinery manufacturer Applied Materials (NASDAQ:AMAT) fell 6% in the afternoon session after the company reported disappointing first 2025 quarter results: its revenue was in line and its inventory levels slightly increased. On the other hand, Applied Materials beat analysts’ EPS and adjusted operating income estimates this quarter. Zooming out, we think this was a mixed quarter. The market seemed to be hoping for more.
StockJumpers analysis and trade plans are uploaded generally 1 HOUR BEFORE MARKETS CLOSE (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.